Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 22, 2025Indian Journal of PharmacologyOpen Access

Safety assessment of dexmedetomidine: Real-world adverse event analysis from the Food and Drug Administration Adverse Events Reporting System public dashboard

View Full Paper
Ask AI
Bookmark
Share

Authors

YYYin YiJJJie JiangYJYoupeng Jin

Discussion

Loading...

Member takes

Overview

Analysis uncovers 1977 adverse events in patients treated with dexmedetomidine, highlighting safety concerns.

Key Points

  • Identified 1977 dexmedetomidine-related adverse events using FDA data, emphasizing safety issues.
  • Data extracted from over 20 million adverse event reports, demonstrating significant safety evaluations.
  • Analysis employed signal quantification methods including reporting odds ratios and Bayesian techniques.
  • Findings suggest the need for ongoing monitoring of dexmedetomidine's adverse effects across multiple organ systems.

Cite This Study

Yi et al. (2025) studied this question.

synapsesocial.com/papers/68af706e7567bf4f94febe89https://doi.org/10.4103/ijp.ijp_688_24
View Full Paper
Ask AI
Bookmark
Share